Tecon Biology Co Ltd
SZSE:002100
Intrinsic Value
Tecon Biology Co., Ltd. engages in the production and sale of animal vaccines, feed, and vegetable protein feed. [ Read More ]
The intrinsic value of one Tecon Biology Co Ltd stock under the Base Case scenario is 8.45 CNY. Compared to the current market price of 7.73 CNY, Tecon Biology Co Ltd is Undervalued by 8%.
Valuation Backtest
Tecon Biology Co Ltd
Run backtest to discover the historical profit from buying and selling Tecon Biology Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Tecon Biology Co Ltd
| Current Assets | 9B |
| Cash & Short-Term Investments | 3.9B |
| Receivables | 1.2B |
| Other Current Assets | 3.9B |
| Non-Current Assets | 7.7B |
| Long-Term Investments | 38.8m |
| PP&E | 6.9B |
| Intangibles | 561.3m |
| Other Non-Current Assets | 109.6m |
| Current Liabilities | 5.5B |
| Accounts Payable | 630.4m |
| Accrued Liabilities | 243.6m |
| Short-Term Debt | 1.1B |
| Other Current Liabilities | 3.5B |
| Non-Current Liabilities | 4B |
| Long-Term Debt | 2.2B |
| Other Non-Current Liabilities | 1.8B |
Earnings Waterfall
Tecon Biology Co Ltd
|
Revenue
|
18.6B
CNY
|
|
Cost of Revenue
|
-17.5B
CNY
|
|
Gross Profit
|
1.1B
CNY
|
|
Operating Expenses
|
-1.3B
CNY
|
|
Operating Income
|
-284.6m
CNY
|
|
Other Expenses
|
-176.2m
CNY
|
|
Net Income
|
-460.8m
CNY
|
Free Cash Flow Analysis
Tecon Biology Co Ltd
Profitability Score
Profitability Due Diligence
Tecon Biology Co Ltd's profitability score is 40/100. The higher the profitability score, the more profitable the company is.
Score
Tecon Biology Co Ltd's profitability score is 40/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Tecon Biology Co Ltd's solvency score is 55/100. The higher the solvency score, the more solvent the company is.
Score
Tecon Biology Co Ltd's solvency score is 55/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Tecon Biology Co Ltd
According to Wall Street analysts, the average 1-year price target for Tecon Biology Co Ltd is 8.74 CNY with a low forecast of 6.97 CNY and a high forecast of 10.5 CNY.
Shareholder Return
Price
Tecon Biology Co Ltd
| Average Annual Return | 2.95% |
| Standard Deviation of Annual Returns | 32.15% |
| Max Drawdown | -65% |
| Market Capitalization | 10.5B CNY |
| Shares Outstanding | 1 365 251 515 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Tecon Biology Co., Ltd. engages in the production and sale of animal vaccines, feed, and vegetable protein feed. The company is headquartered in Urumqi, Xinjiang and currently employs 5,669 full-time employees. The company went IPO on 2006-12-26. The firm's main businesses and products include premium incomes, slaughter processing and distribution of meat products, pig farming, production and distribution of feeds and veterinary drugs, and agricultural products processing. The firm mainly operates its businesses within domestic markets, with Xinjiang Province as its main market.
Contact
IPO
Employees
Officers
The intrinsic value of one Tecon Biology Co Ltd stock under the Base Case scenario is 8.45 CNY.
Compared to the current market price of 7.73 CNY, Tecon Biology Co Ltd is Undervalued by 8%.
You don't have any saved screeners yet
